Contexts of vulnerability and the acceptability of new biomedical HIV prevention technologies among key populations in South Africa: A qualitative study

被引:45
作者
Atujuna, Millicent [1 ]
Newman, Peter A. [2 ]
Wallace, Melissa [1 ]
Eluhu, Megan [1 ]
Rubincam, Clara [2 ]
Brown, Ben [1 ]
Bekker, Linda-Gail [1 ]
机构
[1] Univ Cape Town, Desmond Tutu HIV Fdn, Hlth Sci Fac, Inst Infect Dis, Cape Town, South Africa
[2] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
PREEXPOSURE PROPHYLAXIS; RECTAL MICROBICIDES; YOUNG MEN; VACCINE; SEX; INFECTION; RISK; CHALLENGES; EFFICACY; TRIALS;
D O I
10.1371/journal.pone.0191251
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background New biomedical prevention technologies (NPTs) may contribute to substantially reducing incident HIV infections globally. We explored acceptability and preferences for NPTs among key and other vulnerable populations in two South African townships. Methods We conducted six focus groups and 12 in-depth interviews with adolescents, and adult heterosexual men, women, and men who have sex with men (MSM) (n = 48), and eight indepth interviews with key informant healthcare workers. The interview guide described preexposure prophylaxis (PrEP), vaginal rings, rectal microbicides and HIV vaccines, and explored acceptability and product preferences. Focus groups and in-depth interviews (45-80 minutes) were conducted in Xhosa, audiotaped, and transcribed and translated into English. Data were coded and reviewed using framework analysis with NVivo software. Results Overall, initial enthusiasm and willingness to use NPTs evolved into concerns about how particular NPTs might affect or require alterations in one's everyday lifestyle and practices. Different product preferences and motivations emerged by population based on similarity to existing practices and contexts of vulnerability. Adult women and female adolescents preferred a vaginal ring and HIV vaccine, motivated by longer duration of protection to mitigate feared repercussions from male partners, including threats to their marriage and safety, and a context of ubiquitous rape. Male adolescents preferred an HIV vaccine, seen as protection in serodiscordant relationships and convenient in obviating the HIV stigma and cost involved in buying condoms. Adult men preferred PrEP, given familiarity with oral medications and mistrust of injections, seen as enabling serodiscordant couples to have a child. MSM preferred a rectal microbicide given familiarity with gel-based lubricants, with concerns about duration of protection in the context of unplanned consensual sex and rape. Conclusions Biomedical interventions to prevent HIV transmission, rather than obviating social-structural factors that produce vulnerability, may be limited by these same factors. Implementation of NPTs should engage local communities to understand real-world constraints and strategise to deliver effective, multi-level combination prevention.
引用
收藏
页数:17
相关论文
共 66 条
[41]   Acceptability and Preferences for Hypothetical Rectal Microbicides among a Community Sample of Young Men Who Have Sex with Men and Transgender Women in Thailand: A Discrete Choice Experiment [J].
Newman, Peter A. ;
Cameron, Michael P. ;
Roungprakhon, Surachet ;
Tepjan, Suchon ;
Scarpa, Riccardo .
AIDS AND BEHAVIOR, 2016, 20 (11) :2588-2601
[42]   A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand [J].
Newman, Peter A. ;
Roungprakhon, Surachet ;
Tepjan, Suchon .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2013, 16
[43]  
Newman PA, 2012, EXPERT REV VACCINES, V11, P1, DOI [10.1586/ERV.11.162, 10.1586/erv.11.162]
[44]   Preventive HIV Vaccine Acceptability and Behavioral Risk Compensation among a Random Sample of High-Risk Adults in Los Angeles (LA VOICES) [J].
Newman, Peter A. ;
Lee, Sung-Jae ;
Duan, Naihua ;
Rudy, Ellen ;
Nakazono, Terry K. ;
Boscardin, John ;
Kakinami, Lisa ;
Shoptaw, Steven ;
Diamant, Allison ;
Cunningham, William E. .
HEALTH SERVICES RESEARCH, 2009, 44 (06) :2167-2179
[45]  
NIH National Institute of Allergy and Infectious Diseases, NIH SPONS HIV VACC T
[46]   HIV prevention transformed: the new prevention research agenda [J].
Padian, Nancy S. ;
McCoy, Sandra I. ;
Karim, Salim S. Abdool ;
Hasen, Nina ;
Kim, Julia ;
Bartos, Michael ;
Katabira, Elly ;
Bertozzi, Stefano M. ;
Schwartlaender, Bernhard ;
Cohen, Myron S. .
LANCET, 2011, 378 (9787) :269-278
[47]  
Pettifor A, 2013, JAIDS-J ACQ IMM DEF, V63, pS155, DOI 10.1097/QAI.0b013e31829871fb
[48]  
Preston-Whyte Eleanor M, 2003, Afr J AIDS Res, V2, P89, DOI 10.2989/16085906.2003.9626563
[49]   Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand [J].
Rerks-Ngarm, Supachai ;
Pitisuttithum, Punnee ;
Nitayaphan, Sorachai ;
Kaewkungwal, Jaranit ;
Chiu, Joseph ;
Paris, Robert ;
Premsri, Nakorn ;
Namwat, Chawetsan ;
de Souza, Mark ;
Adams, Elizabeth ;
Benenson, Michael ;
Gurunathan, Sanjay ;
Tartaglia, Jim ;
McNeil, John G. ;
Francis, Donald P. ;
Stablein, Donald ;
Birx, Deborah L. ;
Chunsuttiwat, Supamit ;
Khamboonruang, Chirasak ;
Thongcharoen, Prasert ;
Robb, Merlin L. ;
Michael, Nelson L. ;
Kunasol, Prayura ;
Kim, Jerome H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (23) :2209-2220
[50]   The social structural production of HIV risk among injecting drug users [J].
Rhodes, T ;
Singer, M ;
Bourgois, P ;
Friedman, SR ;
Strathdee, SA .
SOCIAL SCIENCE & MEDICINE, 2005, 61 (05) :1026-1044